| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reports |
From the Departments of Anesthesia and Perioperative Care (T.H., T.L., W.L.Y.), Surgery (N.J.B.), Pathology (A.W.B.), Neurological Surgery (M.T.L., W.L.Y.), and Neurology (W.L.Y.), University of California, San Francisco, Calif.
Correspondence to William L. Young, MD, Center for Cerebrovascular Research, University of California, San Francisco, 1001 Potrero Ave, 3C-38, San Francisco, CA 94110. E-mail CCR{at}anesthesia.ucsf.edu
Abstract
Brain arteriovenous malformations (BAVMs) are congenital vascular lesions that often present as cerebral hemorrhage in young adults. The variable nature of the clinical course, especially with respect to spontaneous hemorrhage, recurrence, growth, and regression, suggests that BAVMs are lesions with active angiogenesis and vascular remodeling. We examined mRNA and protein expression of angiopoietin 1 (Ang1) and Ang2 by semiquantitative reverse transcriptasepolymerase chain reaction, in situ hybridization, and Western blot in BAVMs and control brains obtained from temporal lobectomy for medically intractable seizures. Although Ang1 mRNA levels were similar in BAVMs and controls, Ang1 protein levels were 30% lower in BAVMs than in controls. Ang2 mRNA levels were 40% higher and Ang2 protein levels were 8-fold higher in BAVMs than in controls. In situ hybridization showed that the Ang2 mRNA was localized to the perivascular area in BAVMs. This abnormal balance in the Ang-Tie2 system may, in part, explain the aberrant vascular phenotype in BAVMs.
Key Words: cerebral arteriovenous malformations vascular malformations endothelium angiopoietin Tie2
This article has been cited by other articles:
![]() |
Q. Hao, H. Su, D. A. Marchuk, R. Rola, Y. Wang, W. Liu, W. L. Young, and G.-Y. Yang Increased tissue perfusion promotes capillary dysplasia in the ALK1-deficient mouse brain following VEGF stimulation Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2250 - H2256. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Redondo, A. Martinez-Cuesta, E. G. Quetglas, and M. Idoate Active Angiogenesis in an Extensive Arteriovenous Vascular Malformation: A Possible Therapeutic Target? Arch Dermatol, August 1, 2007; 143(8): 1043 - 1045. [Full Text] [PDF] |
||||
![]() |
E. D. Phelps, D. L. Updike, E. C. Bullen, P. Grammas, and E. W. Howard Transcriptional and posttranscriptional regulation of angiopoietin-2 expression mediated by IGF and PDGF in vascular smooth muscle cells Am J Physiol Cell Physiol, February 1, 2006; 290(2): C352 - C361. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Sun, T. Phung, I. Shiojima, T. Felske, J. N. Upalakalin, D. Feng, T. Kornaga, T. Dor, A. M. Dvorak, K. Walsh, et al. Microvascular patterning is controlled by fine-tuning the Akt signal PNAS, January 4, 2005; 102(1): 128 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hashimoto, G. Wen, M. T. Lawton, N. J. Boudreau, A. W. Bollen, G.-Y. Yang, N. M. Barbaro, R. T. Higashida, C. F. Dowd, V. V. Halbach, et al. Abnormal Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Brain Arteriovenous Malformations * Growth and Bleeding in BAVM: Another Role for MMPs Stroke, April 1, 2003; 34(4): 925 - 931. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |